Quarterly report pursuant to Section 13 or 15(d)

UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

v3.3.1.900
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
 3 Months Ended
Dec. 31, 2015
Dec. 31, 2014
REVENUES    
Neurometric Services $ 24,700 $ 22,700
OPERATING EXPENSES    
Cost of neurometric service revenues 1,200 1,100
Research 22,700 23,800
Product development 123,400 245,500
Sales and marketing 123,200 89,700
General and administrative 377,100 441,800
Total operating expenses 647,600 801,900
OPERATING LOSS (622,900) (779,200)
OTHER INCOME (EXPENSE)    
Interest expense, net (700) (800)
Financing expenses (499,500) $ (50,600)
Loss on extinguishment of debt (2,337,400)
Gain (loss) on derivative liabilities 11,300 $ (39,900)
Total other income (expense) (2,826,300) (91,300)
LOSS BEFORE PROVISION FOR INCOME TAXES (3,449,200) (870,500)
Provision for income taxes 300 3,200
LOSS FROM CONTINUING OPERATIONS (3,449,500) (873,700)
Loss from discontinued operations (1,800) (900)
NET LOSS $ (3,451,300) $ (874,600)
BASIC AND DILUTED NET LOSS PER SHARE    
From continuing operations (in dollars per share) $ (0.03) $ (0.01)
From discontinued operations (in dollars per share) 0.00 0.00
Combined Net Loss (in dollars per share) $ (0.03) $ (0.01)
WEIGHTED AVERAGE SHARES OUTSTANDING:    
Basic and diluted (in shares) 102,417,409 101,667,409